DrugPatentWatch Database Preview

Therapeuticsmd Inc Company Profile

Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for THERAPEUTICSMD INC, and what generic alternatives to THERAPEUTICSMD INC drugs are available?

THERAPEUTICSMD INC has three approved drugs.

There are thirty-nine US patents protecting THERAPEUTICSMD INC drugs.

There are one hundred and forty patent family members on THERAPEUTICSMD INC drugs in nineteen countries and thirty-four supplementary protection certificates in fourteen countries.

Summary for Therapeuticsmd Inc

International Patents:	140
US Patents:	39
Tradenames:	3
Ingredients:	3
NDAs:	3

Drugs and US Patents for Therapeuticsmd Inc

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-001	May 29, 2018		RX	Yes	No	10,471,072
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-001	May 29, 2018		RX	Yes	No	11,123,283		Y
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-001	May 29, 2018		RX	Yes	No	9,180,091		Y
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes	11,103,513
Therapeuticsmd Inc	BIJUVA	estradiol; progesterone	CAPSULE;ORAL	210132-001	Oct 28, 2018		RX	Yes	Yes	11,103,516		Y
Therapeuticsmd Inc	IMVEXXY	estradiol	INSERT;VAGINAL	208564-002	May 29, 2018		RX	Yes	Yes	10,888,516

International Patents for Therapeuticsmd Inc Drugs

Country	Patent Number	Estimated Expiration
Croatia	P20210861
Japan	6682127
Japan	2016534025
Argentina	098160
Australia	2015264003
Brazil	112018011483

Supplementary Protection Certificates for Therapeuticsmd Inc Drugs

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
1453521	300814	Netherlands		PRODUCT NAME: LEVONORGESTREL EN ETHINYLESTRADIOL; NATIONAL REGISTRATION NO/DATE: RVG 117453 20151211; FIRST REGISTRATION: SK 17/0017/15-S 20150211
0771217	07C0001	France		PRODUCT NAME: ETHINYLESTRADIOL BETADEX CLATHRATE; NAT. REGISTRATION NO/DATE: NL 32343 20060710; FIRST REGISTRATION: NL - RVG 31781 20050804
1380301	CA 2009 00017	Denmark		PRODUCT NAME: ETHINYLESTRADIOL (SOM BETADEXCLATHRAT) OG DROSPIRENON; NAT. REG. NO/DATE: 42417 (DK) 20080619; FIRST REG. NO/DATE: NL 33842 20070629
0770388	2009/012	Ireland		PRODUCT NAME: QLAIRA-ESTRADIOL VALERATE/DIENOGEST; NAT REGISTRATION NO/DATE: PA1410/58/1 20090109; FIRST REGISTRATION NO/DATE: BE327792 20081103
2782584	301153	Netherlands		PRODUCT NAME: COMPOSITION CONTAINING BOTH ESTRADIOL (17SS-ESTRADIOL), OPTIONALLY IN THE FORM OF A PHARMACEUTICALLY ACCEPTABLE SALT, HYDRATE OR SOLVATE THEREOF (INCLUDING IN HEMIHYDRATE FORM), AND PROGESTERONE; NATIONAL REGISTRATION NO/DATE: RVG 125821 20210611; FIRST REGISTRATION: BE BE582231 20210406
1453521	CA 2016 00016	Denmark		PRODUCT NAME: LEVONORGESTREL OG ETHINYLOESTRADIOL; NAT. REG. NO/DATE: 56336 20151105; FIRST REG. NO/DATE: SK 17/0017/15-S 20150211

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

• Theragen
• Therapeuticsmd Inc